|Podcasts|December 1, 2011
Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them
Advertisement
Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them
Sam Whitaker, CEO of Greenphire, discusses the company’s success to date with its financial payments technology, global capabilities for next year, and how financial pressures are changing trials for the better.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 DIA Global Annual Meeting: Why Protocol Digitization Has Been So Hard to Automate—Until Now
2
2026 DIA Global Annual Meeting: What Drives Sponsors to Mixed Outsourcing Models and What the Transition Looks Like
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: What the FDA's Real-Time Data Push Actually Means for Sponsors and CROs
5